je.st
news
Tag: zacks
Oracle Co. (ORCL) Upgraded to "Hold" by Zacks Investment Research
2016-01-17 17:54:38| Telecom - Topix.net
According to Zacks, "Oracle posted mixed second quarter fiscal 2016 results wherein earnings of $0.59 beat the Zacks Consensus Estimate by $0.02 but revenues of $8.99 billion missed the same. The company's continuing transition from licensing, where revenues are recognized upfront, to a cloud subscription model where it is realized over the years, will hurt its top line in the near term.
Tags: research
hold
investment
oracle
Penske Automotive Group, Inc. (PAG) Rating Reiterated by Zacks Investment Research
2016-01-17 17:46:49| Auto Dealers - Topix.net
's stock had its "sell" rating reaffirmed by Zacks Investment Research in a research report issued on Sunday, Marketbeat.com reports. According to Zacks, "Penske Automotive's third-quarter 2015 earnings improved year over year but missed the Zacks Consensus Estimate.
Tags: group
research
rating
automotive
O'Reilly Automotive Inc (ORLY) Stock Rating Lowered by Zacks Investment Research
2016-01-17 17:35:33| Apparel - Topix.net
According to Zacks, "O'Reilly's third-quarter 2015 earnings per share and revenues increased year over year and surpassed the respective Zacks Consensus Estimate. Comparable store sales also improved in the reported quarter.
Tags: research
rating
stock
automotive
Northwest Natural Gas Co (NWN) Lifted to "Buy" at Zacks Investment Research
2016-01-17 16:14:46| Energy - Topix.net
The brokerage currently has a $56.00 price objective on the stock. Zacks Investment Research 's target price would indicate a potential upside of 11.75% from the company's current price.
Tags: buy
research
natural
investment
Novo Nordisk A/S (NVO) Receives Sell Rating from Zacks Investment Research
2016-01-17 15:45:50| Biotech - Topix.net
's stock had its "sell" rating reissued by Zacks Investment Research in a research report issued to clients and investors on Sunday, MarketBeat.Com reports. According to Zacks, "Novo Nordisk's third-quarter 2015 results were strong with revenues increased on the back of robust performance from Victoza and Levemir as well as significant contributions from Tresiba and Saxenda.
Tags: research
rating
sell
investment
Sites : [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] next »